Amnon Asher Berger, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Post-Dural Puncture Headache | 2 | 2022 | 53 | 1.470 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2022 | 60 | 0.820 |
Why?
|
Endometrial Neoplasms | 2 | 2022 | 1357 | 0.800 |
Why?
|
Neovascularization, Pathologic | 2 | 2022 | 2640 | 0.750 |
Why?
|
Analgesia, Obstetrical | 1 | 2022 | 169 | 0.720 |
Why?
|
Analgesia, Epidural | 1 | 2022 | 330 | 0.650 |
Why?
|
Anesthesia, Epidural | 1 | 2021 | 233 | 0.630 |
Why?
|
Cannabidiol | 1 | 2020 | 117 | 0.620 |
Why?
|
Anesthesia, Obstetrical | 1 | 2021 | 233 | 0.620 |
Why?
|
beta Catenin | 1 | 2022 | 1043 | 0.570 |
Why?
|
Fibromyalgia | 1 | 2020 | 401 | 0.510 |
Why?
|
Virus Attachment | 1 | 2015 | 55 | 0.510 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1079 | 0.410 |
Why?
|
Angiogenesis Inhibitors | 1 | 2022 | 2049 | 0.410 |
Why?
|
Cytomegalovirus | 1 | 2015 | 755 | 0.370 |
Why?
|
Failed Back Surgery Syndrome | 2 | 2020 | 20 | 0.350 |
Why?
|
Cannabis | 3 | 2021 | 436 | 0.350 |
Why?
|
Analgesics | 3 | 2020 | 1065 | 0.320 |
Why?
|
Cytomegalovirus Infections | 1 | 2015 | 831 | 0.320 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1262 | 0.300 |
Why?
|
Neural Stem Cells | 1 | 2015 | 884 | 0.300 |
Why?
|
Migraine Disorders | 1 | 2020 | 1693 | 0.300 |
Why?
|
Parkinson Disease | 1 | 2021 | 2859 | 0.290 |
Why?
|
Marijuana Abuse | 2 | 2021 | 411 | 0.270 |
Why?
|
Cerebral Palsy | 2 | 2020 | 471 | 0.260 |
Why?
|
Epilepsy | 1 | 2020 | 3267 | 0.250 |
Why?
|
Neuralgia | 2 | 2021 | 600 | 0.230 |
Why?
|
Autonomic Nerve Block | 2 | 2021 | 81 | 0.220 |
Why?
|
Muscle Spasticity | 2 | 2020 | 155 | 0.210 |
Why?
|
Ribs | 2 | 2021 | 252 | 0.200 |
Why?
|
Low Back Pain | 2 | 2021 | 979 | 0.200 |
Why?
|
Oxadiazoles | 1 | 2021 | 94 | 0.200 |
Why?
|
Pelvic Pain | 2 | 2021 | 298 | 0.190 |
Why?
|
Hypogastric Plexus | 1 | 2021 | 10 | 0.190 |
Why?
|
Tietze's Syndrome | 1 | 2020 | 2 | 0.190 |
Why?
|
Athletic Tape | 1 | 2020 | 4 | 0.190 |
Why?
|
Punctures | 1 | 2022 | 370 | 0.180 |
Why?
|
Flank Pain | 1 | 2021 | 43 | 0.180 |
Why?
|
Antiparkinson Agents | 1 | 2021 | 183 | 0.180 |
Why?
|
Tennis Elbow | 1 | 2020 | 16 | 0.180 |
Why?
|
Blood Patch, Epidural | 1 | 2021 | 56 | 0.180 |
Why?
|
Neuralgia, Postherpetic | 1 | 2020 | 41 | 0.170 |
Why?
|
Muscle Relaxants, Central | 1 | 2020 | 92 | 0.170 |
Why?
|
Bupivacaine | 2 | 2021 | 413 | 0.170 |
Why?
|
Azepines | 1 | 2022 | 330 | 0.170 |
Why?
|
Post-Traumatic Headache | 1 | 2021 | 65 | 0.170 |
Why?
|
Catechol O-Methyltransferase | 1 | 2021 | 251 | 0.170 |
Why?
|
Hematuria | 1 | 2021 | 233 | 0.170 |
Why?
|
Nerve Compression Syndromes | 1 | 2021 | 160 | 0.170 |
Why?
|
Catheters | 1 | 2022 | 425 | 0.160 |
Why?
|
Spinal Puncture | 1 | 2021 | 281 | 0.160 |
Why?
|
Pituitary-Adrenal System | 1 | 2022 | 552 | 0.160 |
Why?
|
Cannabinoids | 1 | 2021 | 173 | 0.150 |
Why?
|
Cell Differentiation | 1 | 2015 | 11481 | 0.150 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2022 | 700 | 0.150 |
Why?
|
Platelet-Rich Plasma | 1 | 2020 | 179 | 0.150 |
Why?
|
Herpes Zoster | 1 | 2020 | 251 | 0.150 |
Why?
|
Anesthesia, Conduction | 1 | 2020 | 261 | 0.140 |
Why?
|
Physical Therapy Modalities | 1 | 2020 | 536 | 0.140 |
Why?
|
Triazoles | 1 | 2022 | 904 | 0.130 |
Why?
|
Acupuncture Therapy | 1 | 2021 | 480 | 0.130 |
Why?
|
Dexmedetomidine | 1 | 2020 | 316 | 0.130 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2020 | 622 | 0.130 |
Why?
|
Endometriosis | 2 | 2021 | 874 | 0.130 |
Why?
|
Benzamides | 1 | 2020 | 1369 | 0.120 |
Why?
|
Spinal Diseases | 1 | 2020 | 559 | 0.120 |
Why?
|
Humans | 30 | 2022 | 760621 | 0.120 |
Why?
|
Analgesics, Opioid | 5 | 2021 | 3763 | 0.120 |
Why?
|
Spinal Cord Injuries | 1 | 2020 | 924 | 0.100 |
Why?
|
Piperidines | 1 | 2020 | 1650 | 0.100 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2022 | 3484 | 0.100 |
Why?
|
Intercostal Nerves | 2 | 2021 | 27 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1721 | 0.090 |
Why?
|
Databases, Nucleic Acid | 1 | 2010 | 204 | 0.080 |
Why?
|
Anesthetics, Local | 3 | 2021 | 1001 | 0.080 |
Why?
|
Neuromuscular Agents | 2 | 2021 | 148 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2879 | 0.080 |
Why?
|
3' Untranslated Regions | 1 | 2010 | 514 | 0.080 |
Why?
|
Patient Selection | 1 | 2019 | 4283 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2021 | 2282 | 0.070 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2138 | 0.060 |
Why?
|
Psychotic Disorders | 1 | 2020 | 3193 | 0.060 |
Why?
|
Electric Stimulation Therapy | 2 | 2021 | 613 | 0.060 |
Why?
|
Syndrome | 2 | 2021 | 3280 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 4371 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8056 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10344 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4878 | 0.050 |
Why?
|
Female | 7 | 2022 | 391270 | 0.050 |
Why?
|
RNA, Viral | 1 | 2010 | 2838 | 0.050 |
Why?
|
Splanchnic Nerves | 1 | 2021 | 16 | 0.050 |
Why?
|
Sensory System Agents | 1 | 2021 | 21 | 0.050 |
Why?
|
Rhizotomy | 1 | 2020 | 30 | 0.050 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2020 | 38 | 0.050 |
Why?
|
omega-Conotoxins | 1 | 2020 | 18 | 0.050 |
Why?
|
Electroacupuncture | 1 | 2021 | 66 | 0.040 |
Why?
|
Hypnosis | 1 | 2021 | 82 | 0.040 |
Why?
|
Sympathectomy | 1 | 2021 | 93 | 0.040 |
Why?
|
Pregnancy | 1 | 2022 | 29749 | 0.040 |
Why?
|
Drug Administration Routes | 1 | 2020 | 150 | 0.040 |
Why?
|
Capsaicin | 1 | 2021 | 231 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29658 | 0.040 |
Why?
|
Adrenergic alpha-2 Receptor Agonists | 1 | 2020 | 91 | 0.040 |
Why?
|
Denervation | 1 | 2021 | 277 | 0.040 |
Why?
|
Clonidine | 1 | 2020 | 170 | 0.040 |
Why?
|
Epidural Space | 1 | 2020 | 122 | 0.040 |
Why?
|
Dysmenorrhea | 1 | 2020 | 98 | 0.040 |
Why?
|
Tissue Adhesions | 1 | 2020 | 222 | 0.040 |
Why?
|
Afghan Campaign 2001- | 1 | 2021 | 296 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2020 | 65017 | 0.040 |
Why?
|
Injections, Epidural | 1 | 2021 | 200 | 0.040 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2021 | 432 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18416 | 0.040 |
Why?
|
Ureter | 1 | 2021 | 375 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2021 | 523 | 0.040 |
Why?
|
Mutation | 1 | 2022 | 29932 | 0.040 |
Why?
|
Naltrexone | 1 | 2020 | 317 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2019 | 659 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15697 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2020 | 694 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2019 | 715 | 0.030 |
Why?
|
Back Pain | 1 | 2020 | 543 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2021 | 2116 | 0.030 |
Why?
|
Muscles | 1 | 2020 | 1581 | 0.030 |
Why?
|
Sex Distribution | 1 | 2021 | 2295 | 0.030 |
Why?
|
Constipation | 1 | 2020 | 561 | 0.030 |
Why?
|
Narcotic Antagonists | 1 | 2020 | 583 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1218 | 0.030 |
Why?
|
Nephrectomy | 1 | 2021 | 1016 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2893 | 0.030 |
Why?
|
MicroRNAs | 1 | 2010 | 3790 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 944 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 2019 | 1745 | 0.030 |
Why?
|
Nerve Block | 1 | 2021 | 688 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2022 | 80372 | 0.030 |
Why?
|
Adult | 3 | 2022 | 219994 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1881 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1869 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2021 | 2145 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2021 | 1801 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4107 | 0.020 |
Why?
|
Anticonvulsants | 1 | 2021 | 1879 | 0.020 |
Why?
|
Pain Measurement | 1 | 2021 | 3528 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2714 | 0.020 |
Why?
|
Pyrimidines | 1 | 2020 | 3016 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8482 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5961 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3616 | 0.020 |
Why?
|
Health Care Costs | 1 | 2020 | 3258 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10551 | 0.020 |
Why?
|
Pain | 1 | 2020 | 5066 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7064 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11152 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 6957 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2010 | 2005 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6048 | 0.010 |
Why?
|
Quality of Life | 1 | 2020 | 13308 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54303 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2010 | 11903 | 0.010 |
Why?
|
Male | 2 | 2021 | 359744 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 87810 | 0.010 |
Why?
|
Child | 1 | 2020 | 79806 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13981 | 0.010 |
Why?
|
Aged | 1 | 2019 | 169152 | 0.000 |
Why?
|
Middle Aged | 1 | 2019 | 220352 | 0.000 |
Why?
|
Mice | 1 | 2010 | 81208 | 0.000 |
Why?
|
Animals | 1 | 2010 | 167963 | 0.000 |
Why?
|